| | |
Mean (SD)
|
Effect size d(95% CI)
|
|---|
|
Outcome measure
|
Group
|
Pre ctrl
|
Post ctrl/Pre tx
|
Post tx
|
7-month follow-up
|
Between-group, Post tx
|
Between-group, 7mo
|
Within-group, Pre tx – Post tx
|
Within-group, Post tx - 7mo
|
|---|
|
BDI-II
| | | | | | | | | |
| |
ICBT
|
26.10 (6.7)
|
19.57 (8.0)
|
12.26 (6.6)
|
10.36 (10.6)
|
0.33 (−0.42 – 1.07)
|
0.45 (−0.23 – 1.14)
|
1.04 (0.61 – 1.48)
|
0.20 (−0.10 – 0.50)
|
| |
IPDT
|
26.29 (6.8)
|
22.29 (7.4)
|
14.60 (8.5)
|
15.42 (12.6)
| | |
1.06 (0.45 – 1.67)
|
−0.13 (−0.69 – 0.43)
|
|
MADRS-S
| | | | | | | | | |
| |
ICBT
|
24.17 (4.6)
|
18.30 (6.8)
|
12.78 (7.8)
|
11.11 (8.2)
|
0.28 (−0.46 – 1.03)
|
0.32 (−0.36 – 1.00)
|
0.88 (0.43 – 1.34)
|
0.18 (−0.13 – 0.49)
|
| |
IPDT
|
22.64 (5.9)
|
19.93 (5.4)
|
14.90 (6.7)
|
13.75 (8.4)
| | |
0.90 (0.21 – 1.58)
|
0.00 (−0.44 – 0.44)
|
|
PHQ-9
| | | | | | | | | |
| |
ICBT
|
13.03 (4.0)
|
10.63 (5.1)
|
6.17 (5.1)
|
5.75 (6.0)
|
0.11 (−0.63 – 0.85)
|
0.36 (−0.32 – 1.04)
|
1.02 (0.46 – 1.57)
|
0.19 (−0.12 – 0.50)
|
| |
IPDT
|
14.14 (5.1)
|
11.93 (3.9)
|
6.70 (4.3)
|
7.92 (6.4)
| | |
1.08 (0.65 – 1.51)
|
−0.21 (−0.56 – 0.15)
|
|
GAD-7
| | | | | | | | | |
| |
ICBT
|
8.60 (3.8)
|
7.33 (4.8)
|
5.09 (4.3)
|
3.71 (4.9)
|
0.14 (−0.61 – 0.88)
|
0.70 (0.00 – 1.39)
|
0.56 (0.15 – 0.97)
|
0.27 (0.01 – 0.53)
|
| |
IPDT
|
7.57 (4.7)
|
8.71 (5.2)
|
5.70 (4.9)
|
7.08 (4.8)
| | |
0.63 (−0.05 – 1.31)
|
−0.45 (−1.07 – 0.17)
|
|
BAI
| | | | | | | | | |
| |
ICBT
|
19.13 (10.0)
|
12.67 (8.6)
|
9.43 (8.1)
|
7.93 (9.9)
|
0.22 (−0.53 – 0.96)
|
0.38 (−0.30 – 1.06)
|
0.39 (0.04 – 0.75)
|
0.09 (−0.24 – 0.42)
|
| |
IPDT
|
18.07 (9.7)
|
15.29 (9.9)
|
11.10 (6.6)
|
11.83 (11.0)
| | |
0.61 (−0.13 – 1.35)
|
−0.23 (−0.74 – 0.28)
|
|
QOLI
| | | | | | | | | |
| |
ICBT
|
−0.07 (1.1)
|
0.15 (1.5)
|
0.58 (1.6)
|
1.49 (1.7)
|
0.32 (−0.43 – 1.07)
|
0.67 (−0.02 – 1.36)
|
0.45 (0.06 – 0.83)
|
0.45 (0.13 – 0.78)
|
| |
IPDT
|
−0.19 (1.6)
|
0.33 (1.4)
|
0.09 (1.2)
|
0.46 (1.1)
| | |
0.22 (−0.14 – 0.57)
|
−0.20 (−0.56 – 0.16)
|
-
Note: Pre ctrl = Time point before original trial started; Post ctrl/Pre tx = Time point at the end of the original trial period which also served as pre-treatment assessment in this study; Post tx = Time point at the end of the treatment period; BDI-II = Beck Depression Inventory-II; MADRS-S = Montgomery Åsberg Depression Rating Scale - Self Rated; PHQ-9 = 9-item Patient Health Questionnaire Depression Scale; GAD-7 = 7-item Patient Health Questionnaire Generalized Anxiety Disorder Scale; BAI = Beck Anxiety Inventory; QOLI = Quality of Life Inventory; ICBT = Internet-based cognitive-behavioral therapy; IPDT = Internet-based psychodynamic therapy.
